Trademark: 97648630
Word
B
Status
Registered
Status Code
700
Status Date
Tuesday, August 13, 2024
Serial Number
97648630
Registration Number
7476146
Registration Date
Tuesday, August 13, 2024
Mark Type
3
Filing Date
Wednesday, October 26, 2022
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Biosynth AG - Original Registrant

Classifications
40 Custom manufacture of medicines and diagnostics for others; Custom manufacturing for others in the pharmaceutical, diagnostic, veterinary, biotechnology and chemistry fields
39 Packaging and filling articles to the order and specification of others; Warehouse services
5 Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
1 Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
42 Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of medicines and diagnostics
The mark consists of the stylized letter B with an angle design on the bottom left of the B.
BIOSYNTH
Color is not claimed as a feature of the mark.

Trademark Events
Oct 29, 2022
New Application Entered
Nov 9, 2022
New Application Office Supplied Data Entered
Nov 10, 2022
Notice Of Design Search Code E-Mailed
Aug 9, 2023
Assigned To Examiner
Aug 11, 2023
Approved For Pub - Principal Register
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Sep 19, 2023
Published For Opposition
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 26, 2024
Use Amendment Filed
Apr 26, 2024
Teas Statement Of Use Received
May 25, 2024
Case Assigned To Intent To Use Paralegal
May 25, 2024
Statement Of Use Processing Complete
Jul 7, 2024
Allowed Principal Register - Sou Accepted
Jul 7, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 13, 2024
Registered-Principal Register
Aug 13, 2024
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24